Swedish Biotech and Medtech Delegation to Singapore - IONLACE AB (2025)

Purpose and goal

IONLACE is launching a limited early access program for select partners looking to be at the forefront of biologics innovation. We’ve built a modular protein design platform that enables rapid, combinatorial development of multi-specifics, fusion proteins, and other complex biologics. It’s AI-guided, experimentally validated, and built to replace slow, bespoke workflows with scalable, programmable design. We don’t sell predictions. We deliver validated molecules that work.

Expected effects and result

We expect a rewarding delegation trip to Singapore where we´ll create new connections in the local ecosystem that could help us expand our offering to a new, exciting and emerging biotechnology region of the world.

Planned approach and implementation

We´ll join the delegation on the planned events and visits to engage with local companies and stakeholders. We also intend to participate during the Asia Bio Forum and actively seek out partnership discussions with other companies.